Impact of ERCC1 gene polymorphisms on response to cisplatin based therapy in oral squamous cell carcinoma (OSCC) patients

Background and Objectives: Cisplatin is one of the major drugs that used in the treatment of oral cancer.Excision repair cross-complementation group 1 (ERCC1) is a key DNA repair gene in the nucleotide excision repair pathway which is activated in the repair of intra- and interstrand DNA crosslink c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: M L Avinash Tejasvi (Autor), G Maragathavalli (Autor), Uday Kumar Putcha (Autor), M Ramakrishna (Autor), R Vijayaraghavan (Autor), C K Anulekha Avinash (Autor)
Format: Llibre
Publicat: Wolters Kluwer Medknow Publications, 2020-01-01T00:00:00Z.
Matèries:
Accés en línia:Connect to this object online.
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Internet

Connect to this object online.

3rd Floor Main Library

Detall dels fons de 3rd Floor Main Library
Signatura: A1234.567
Còpia 1 Disponible